Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neuron-specific vesicular protein calcyon is encoded by the CALY gene and plays a role in regulating calcium release after stimulation of purinergic or muscarinic receptors. It interacts with the D1 dopamine receptor indirectly through PSD-95 and is involved in various neuropsychiatric disorders. This molecule is not typically considered a therapeutic target in the same way as receptors or enzymes but is important for understanding dopamine receptor signaling and its implications in neuropsychiatric disorders.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neuron-specific vesicular protein calcyon (CALY).